Trial
NCT05019521
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Geographic Atrophy
Intervention
Danicopan
Why stopped
Lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-05